Correlation Between Phathom Pharmaceuticals and Cullinan Oncology
Can any of the company-specific risk be diversified away by investing in both Phathom Pharmaceuticals and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phathom Pharmaceuticals and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phathom Pharmaceuticals and Cullinan Oncology LLC, you can compare the effects of market volatilities on Phathom Pharmaceuticals and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phathom Pharmaceuticals with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phathom Pharmaceuticals and Cullinan Oncology.
Diversification Opportunities for Phathom Pharmaceuticals and Cullinan Oncology
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Phathom and Cullinan is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Phathom Pharmaceuticals and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Phathom Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phathom Pharmaceuticals are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Phathom Pharmaceuticals i.e., Phathom Pharmaceuticals and Cullinan Oncology go up and down completely randomly.
Pair Corralation between Phathom Pharmaceuticals and Cullinan Oncology
Given the investment horizon of 90 days Phathom Pharmaceuticals is expected to under-perform the Cullinan Oncology. In addition to that, Phathom Pharmaceuticals is 1.62 times more volatile than Cullinan Oncology LLC. It trades about -0.16 of its total potential returns per unit of risk. Cullinan Oncology LLC is currently generating about -0.13 per unit of volatility. If you would invest 1,793 in Cullinan Oncology LLC on September 5, 2024 and sell it today you would lose (513.00) from holding Cullinan Oncology LLC or give up 28.61% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Phathom Pharmaceuticals vs. Cullinan Oncology LLC
Performance |
Timeline |
Phathom Pharmaceuticals |
Cullinan Oncology LLC |
Phathom Pharmaceuticals and Cullinan Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Phathom Pharmaceuticals and Cullinan Oncology
The main advantage of trading using opposite Phathom Pharmaceuticals and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phathom Pharmaceuticals position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.The idea behind Phathom Pharmaceuticals and Cullinan Oncology LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Cullinan Oncology vs. Bolt Biotherapeutics | Cullinan Oncology vs. Day One Biopharmaceuticals | Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Autolus Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |